AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-21.24%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$207M
AUM Growth
+$207M
(-47%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-53.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
Natera
NTRA
|
$3.58M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$87.7M |
| 2 |
Denali Therapeutics
DNLI
|
$25.3M |
| 3 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
$1.32M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
| $70.5M | 34.02% | 36,335,375 | – | – |
|
|
2
Denali Therapeutics
DNLI
$2.23B
| $59.2M | 28.57% | 2,568,749 -1,100,000 | -30% | -$25.3M |
|
3
Erasca
ERAS
$445M
| $33.3M | 16.06% | 11,055,554 | – | – |
|
|
VERV
4
DELISTED
Verve Therapeutics
VERV
| $29M | 13.98% | 2,008,809 | – | – |
|
|
KRTX
5
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.45M | 2.63% | 30,000 -482,872 | -94% | -$87.7M |
|
|
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $4.6M | 2.22% | 3,798,926 | – | – |
|
|
7
Natera
NTRA
$23.1B
| $3.58M | 1.73% | +64,441 | New | +$3.58M |
|
|
UBX
8
DELISTED
Unity Biotechnology
UBX
| $1.64M | 0.79% | 1,004,817 | – | – |
|
|
MTCR
9
DELISTED
Metacrine, Inc. Common Stock
MTCR
| – | – | -2,940,503 | Closed | -$1.32M |
|